PLAU and carcinoma: In vitro studies suggest that TSP-1 may promote tumor cell adhesion and invasion by up-regulating urokinase plasminogen activator and its receptor[14] but  in clinical studies overexpression has been associated with a lower MVD score and a better clinical outcome in several carcinomas[15].